PCN472 PATIENT REPORTED HEALTH STATE UTILITIES IN CUTANEOUS T-CELL LYMPHOMA (CTCL) - AN ANALYSIS OF EQ-5D AND SKINDEX-29 DATA COLLECTED FROM THE ALCANZA TRIAL
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.664
https://www.valueinhealthjournal.com/article/S1098-3015(19)33042-6/fulltext
Section Title :
Section Order :
10577
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33042-6&doi=10.1016/j.jval.2019.09.664